Methods and compositions employing a novel stearoyl-CoA desaturase-hSCD5
A cDNA encoding a novel human stearoy-CoA desaturase (dubbed “hSCD5”) as well as vectors and cells comprising such polynucleotide are disclosed. Also described are assay methods for determining the ability of small molecules and other chemical agents to increase or decrease he enzymatic activity and/or gene expression level of hSCD5 as well as processes for using such agents to treat, prevent or diagnose a variety of diseases and other conditions.
1. A method for treating low HDL levels or elevated triglyceride levels in a patient afflicted therewith, comprising administering to said patient an agent that modulates desaturase activity of a human stearoyl-CoA desaturase 5 (hSCD5) having the amino acid sequence of SEQ ID NO: 2 wherein said agent is administered in an amount sufficient to decrease hSCD5 desaturase activity in said patient.
2. The method of claim 1 , wherein said activity is enzyme activity.
3. The method of claim 1 , wherein said activity is expression of a polynucleotide encoding hSCD1 polypeptide.
4. The method of claim 3 , wherein said expression is gene transcription.
5. The method of claim 1 , wherein said agent modulates a transcription factor.
6. The method of claim 1 , wherein said agent is selected from the group consisting of retinoid X receptors (RXRs), peroxisomal proliferation-activated receptor (PPAR) transcription factors, the steroid response element binding proteins (SREBP-1 and SREBP-2), REV-ERBα, ADD-1, EBPα, CREB binding protein, P300, HNF 4, RAR, LXR, and RORα.